Clinical Trial Update: Omega 3 Polyunsaturated Fatty Acid Supplements (PUFAs) and Microvolt T Wave Alternans (TWA) in Patients With Ventricular Arrhythmia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating omega-3 polyunsaturated fatty acid supplements and microvolt T wave alternans in patients with ventricular arrhythmia has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Arrhythmia

Drugs mentioned

• Omega-3 polyunsaturated fatty acid supplements (Omega-3 fatty acids (EPA/DHA))

Snippet

Sponsor: University of Dundee | Conditions: Arrhythmia, Defibrillators, Implantable | Phase 4 | Status: WITHDRAWN